Related Experiment Videos
Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants
1Department of Neonatal Medicine, Royal Prince Alfred Hospital, NSW, Australia.
Insights
Predicting dexamethasone response in preterm infants is possible. Gestational age, pulmonary interstitial emphysema, and ventilation index before treatment help forecast extubation success.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Dexamethasone is used to aid ventilation weaning in preterm infants.
- Individual responses to dexamethasone vary significantly.
- Predictive factors for dexamethasone efficacy in this population are not well-established.
Purpose of the Study:
- To identify factors that predict individual responses to dexamethasone in preterm infants.
- To evaluate the association between infant characteristics, ventilation parameters, and dexamethasone outcomes.
Main Methods:
- Retrospective cohort study of 74 preterm infants receiving dexamethasone for ventilation weaning.
- Analysis of demographic factors, ventilation parameters, and dexamethasone administration details.
- Assessment of radiographic findings and key outcome variables including time to extubation and mortality.
Main Results:
- While most infants improved, response variability was significant.
- Infants extubated within 6 days were more mature, had less pulmonary interstitial emphysema (PIE) or pneumothorax, and lower pre-treatment ventilation index (VI).
- Multiple linear regression identified prematurity, PIE, and pre-treatment VI as significant predictors for time to extubation (adjusted R2 = 0.5126).
Conclusions:
- Gestational age, presence of PIE, and pre-treatment VI are significant predictors of dexamethasone response in preterm infants.
- These factors can help anticipate individual infant outcomes and guide treatment strategies.
- Further research may refine predictive models for dexamethasone therapy in neonates.
Aims:
To evaluate factors predictive of individual response to dexamethasone in preterm infants.
Methods:
A cohort of 74 preterm infants born between January 1993 and February 1996 was studied retrospectively. All of them had received dexamethasone to facilitate weaning from artificial ventilation. Demographic factors, ventilation parameters, and details of dexamethasone administration were recorded from the medical and nursing notes. Radiographs were assessed by one observer who was unaware of the clinical condition of the infant or the outcome. Outcome variables examined included change in ventilation index (VI) at 36-48 hours, the number of days to extubation from the start of dexamethasone, and death before extubation.
Results:
Most babies improved but changes in VI at 36-48 hours ranged from substantial deterioration to dramatic improvement. No identifiable factors were significantly associated with this range of response. The median time to extubation was 6 days. The 36 babies who extubated within the first 6 days were: significantly more mature; less likely to have pulmonary interstitial emphysema (PIE) or pneumothorax; and had significantly lower VIs in the 12 hours preceding dexamethasone treatment. The postconceptional age at extubation was the same whether babies were extubated within or after the first 6 days. Multiple linear regression confirmed a significant association between number of days to extubation and the three factors described above (adjusted R2 = 0.5126).
Conclusions:
Individual responses to dexamethasone can be partly predicted by gestation, the presence of PIE, and the VI before dexamethasone administration.